EU pancreas

An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease

R. Milne, C. La Vecchia, Kristel Van Steen, S. Hahn, M. Buchholz, E. Costello, I. Esposito, J. D. Hoheisel, B. Lange, N. Lopez-Bigas, C. W. Michalski, F. X. Real, A. Brand, N. Malats, Núria Malats, Carlo LaVecchia, Kristel Van Steen, Drazenka Macic, Timur Ceric, Juan Iovanna & 31 others Stephan Hahn, Jorg Kleeff, Maria Gazouli, Christos Dervenis, Peter Hegyi, Ralph Ruhl, Amir Shafat, Linda Sharp, Anwar Rayan, Adriano DeCarli, Giampolo Tortora, Audrius Sileikis, Giedrius Barauskas, Sonja Eriksson Steigen, Tone Ikdahl, Ewa Malecka-Panas, Filipe Santos Silva, Traian Sorin Barbu, Irinel Popescu, Maria Durisova, Magdalena Majekova, Vita Dolzan, Lutfi Genc, Hatice Yildirim, Tajana Crnogorac-Jurcevic, Angela Brand, Roger Milne, Eithne Costello, Malte Bulchholz, Bill Greenhalf, behalf of the COST Action BM1204 participants

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Large-scale international collaboration is essential to decipher relevant information in the context of omics-scale interrogations in cancer research. This is even more important for rare and fatal diseases like pancreas cancer (PC). Methods: The COST Action BM1204 is a unique platform to facilitate the collaboration of a broad range of European and international PC multidisciplinary research groups in order to: (1) integrate knowledge and experience in a multidisciplinary way 'from cell to society', (2) promote the application of uniform study tools and protocols, (3) foster their optimal use by early-stage researchers, (4) enhance the mobility and training of researchers, and (5) disseminate the results produced to the broader society. Results: This Action will develop novel interdisciplinary tools for collaborative research to improve our understanding of PC and its prevention, diagnosis and treatment. It also aims to answer questions related to the etiology, early detection, evidence-based and personalized treatment, and health management for PC. Furthermore, the Action will contribute to new insights into PC personalized medicine and beyond as well as to the understanding of complex and rare diseases taking PC as a best practice example. The Action aims at attracting young scholars across a range of disciplines in collaboration with more experienced researchers and enhancing active European participation in the international scenario of PC research. Conclusion: The ultimate aim is to foster PC research in Europe and to coordinate this effort with other international initiatives to reduce disease mortality.

Original languageEnglish
Pages (from-to)305-312
Number of pages8
JournalPublic Health Genomics
Volume16
Issue number6
DOIs
Publication statusPublished - 20-04-2013

Fingerprint

Rare Diseases
Pancreatic Neoplasms
Pancreas
Public Health
Research
Research Personnel
Precision Medicine
Practice Guidelines
Mortality
Health
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Cite this

Milne, R., La Vecchia, C., Van Steen, K., Hahn, S., Buchholz, M., Costello, E., ... behalf of the COST Action BM1204 participants (2013). EU pancreas: An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease. Public Health Genomics, 16(6), 305-312. https://doi.org/10.1159/000355937
Milne, R. ; La Vecchia, C. ; Van Steen, Kristel ; Hahn, S. ; Buchholz, M. ; Costello, E. ; Esposito, I. ; Hoheisel, J. D. ; Lange, B. ; Lopez-Bigas, N. ; Michalski, C. W. ; Real, F. X. ; Brand, A. ; Malats, N. ; Malats, Núria ; LaVecchia, Carlo ; Van Steen, Kristel ; Macic, Drazenka ; Ceric, Timur ; Iovanna, Juan ; Hahn, Stephan ; Kleeff, Jorg ; Gazouli, Maria ; Dervenis, Christos ; Hegyi, Peter ; Ruhl, Ralph ; Shafat, Amir ; Sharp, Linda ; Rayan, Anwar ; DeCarli, Adriano ; Tortora, Giampolo ; Sileikis, Audrius ; Barauskas, Giedrius ; Eriksson Steigen, Sonja ; Ikdahl, Tone ; Malecka-Panas, Ewa ; Silva, Filipe Santos ; Barbu, Traian Sorin ; Popescu, Irinel ; Durisova, Maria ; Majekova, Magdalena ; Dolzan, Vita ; Genc, Lutfi ; Yildirim, Hatice ; Crnogorac-Jurcevic, Tajana ; Brand, Angela ; Milne, Roger ; Costello, Eithne ; Bulchholz, Malte ; Greenhalf, Bill ; behalf of the COST Action BM1204 participants. / EU pancreas : An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease. In: Public Health Genomics. 2013 ; Vol. 16, No. 6. pp. 305-312.
@article{2456e0af5bb042c59455c0cd76c26617,
title = "EU pancreas: An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease",
abstract = "Background: Large-scale international collaboration is essential to decipher relevant information in the context of omics-scale interrogations in cancer research. This is even more important for rare and fatal diseases like pancreas cancer (PC). Methods: The COST Action BM1204 is a unique platform to facilitate the collaboration of a broad range of European and international PC multidisciplinary research groups in order to: (1) integrate knowledge and experience in a multidisciplinary way 'from cell to society', (2) promote the application of uniform study tools and protocols, (3) foster their optimal use by early-stage researchers, (4) enhance the mobility and training of researchers, and (5) disseminate the results produced to the broader society. Results: This Action will develop novel interdisciplinary tools for collaborative research to improve our understanding of PC and its prevention, diagnosis and treatment. It also aims to answer questions related to the etiology, early detection, evidence-based and personalized treatment, and health management for PC. Furthermore, the Action will contribute to new insights into PC personalized medicine and beyond as well as to the understanding of complex and rare diseases taking PC as a best practice example. The Action aims at attracting young scholars across a range of disciplines in collaboration with more experienced researchers and enhancing active European participation in the international scenario of PC research. Conclusion: The ultimate aim is to foster PC research in Europe and to coordinate this effort with other international initiatives to reduce disease mortality.",
author = "R. Milne and {La Vecchia}, C. and {Van Steen}, Kristel and S. Hahn and M. Buchholz and E. Costello and I. Esposito and Hoheisel, {J. D.} and B. Lange and N. Lopez-Bigas and Michalski, {C. W.} and Real, {F. X.} and A. Brand and N. Malats and N{\'u}ria Malats and Carlo LaVecchia and {Van Steen}, Kristel and Drazenka Macic and Timur Ceric and Juan Iovanna and Stephan Hahn and Jorg Kleeff and Maria Gazouli and Christos Dervenis and Peter Hegyi and Ralph Ruhl and Amir Shafat and Linda Sharp and Anwar Rayan and Adriano DeCarli and Giampolo Tortora and Audrius Sileikis and Giedrius Barauskas and {Eriksson Steigen}, Sonja and Tone Ikdahl and Ewa Malecka-Panas and Silva, {Filipe Santos} and Barbu, {Traian Sorin} and Irinel Popescu and Maria Durisova and Magdalena Majekova and Vita Dolzan and Lutfi Genc and Hatice Yildirim and Tajana Crnogorac-Jurcevic and Angela Brand and Roger Milne and Eithne Costello and Malte Bulchholz and Bill Greenhalf and {behalf of the COST Action BM1204 participants}",
year = "2013",
month = "4",
day = "20",
doi = "10.1159/000355937",
language = "English",
volume = "16",
pages = "305--312",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "S. Karger AG",
number = "6",

}

Milne, R, La Vecchia, C, Van Steen, K, Hahn, S, Buchholz, M, Costello, E, Esposito, I, Hoheisel, JD, Lange, B, Lopez-Bigas, N, Michalski, CW, Real, FX, Brand, A, Malats, N, Malats, N, LaVecchia, C, Van Steen, K, Macic, D, Ceric, T, Iovanna, J, Hahn, S, Kleeff, J, Gazouli, M, Dervenis, C, Hegyi, P, Ruhl, R, Shafat, A, Sharp, L, Rayan, A, DeCarli, A, Tortora, G, Sileikis, A, Barauskas, G, Eriksson Steigen, S, Ikdahl, T, Malecka-Panas, E, Silva, FS, Barbu, TS, Popescu, I, Durisova, M, Majekova, M, Dolzan, V, Genc, L, Yildirim, H, Crnogorac-Jurcevic, T, Brand, A, Milne, R, Costello, E, Bulchholz, M, Greenhalf, B & behalf of the COST Action BM1204 participants 2013, 'EU pancreas: An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease', Public Health Genomics, vol. 16, no. 6, pp. 305-312. https://doi.org/10.1159/000355937

EU pancreas : An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease. / Milne, R.; La Vecchia, C.; Van Steen, Kristel; Hahn, S.; Buchholz, M.; Costello, E.; Esposito, I.; Hoheisel, J. D.; Lange, B.; Lopez-Bigas, N.; Michalski, C. W.; Real, F. X.; Brand, A.; Malats, N.; Malats, Núria; LaVecchia, Carlo; Van Steen, Kristel; Macic, Drazenka; Ceric, Timur; Iovanna, Juan; Hahn, Stephan; Kleeff, Jorg; Gazouli, Maria; Dervenis, Christos; Hegyi, Peter; Ruhl, Ralph; Shafat, Amir; Sharp, Linda; Rayan, Anwar; DeCarli, Adriano; Tortora, Giampolo; Sileikis, Audrius; Barauskas, Giedrius; Eriksson Steigen, Sonja; Ikdahl, Tone; Malecka-Panas, Ewa; Silva, Filipe Santos; Barbu, Traian Sorin; Popescu, Irinel; Durisova, Maria; Majekova, Magdalena; Dolzan, Vita; Genc, Lutfi; Yildirim, Hatice; Crnogorac-Jurcevic, Tajana; Brand, Angela; Milne, Roger; Costello, Eithne; Bulchholz, Malte; Greenhalf, Bill; behalf of the COST Action BM1204 participants.

In: Public Health Genomics, Vol. 16, No. 6, 20.04.2013, p. 305-312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - EU pancreas

T2 - An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease

AU - Milne, R.

AU - La Vecchia, C.

AU - Van Steen, Kristel

AU - Hahn, S.

AU - Buchholz, M.

AU - Costello, E.

AU - Esposito, I.

AU - Hoheisel, J. D.

AU - Lange, B.

AU - Lopez-Bigas, N.

AU - Michalski, C. W.

AU - Real, F. X.

AU - Brand, A.

AU - Malats, N.

AU - Malats, Núria

AU - LaVecchia, Carlo

AU - Van Steen, Kristel

AU - Macic, Drazenka

AU - Ceric, Timur

AU - Iovanna, Juan

AU - Hahn, Stephan

AU - Kleeff, Jorg

AU - Gazouli, Maria

AU - Dervenis, Christos

AU - Hegyi, Peter

AU - Ruhl, Ralph

AU - Shafat, Amir

AU - Sharp, Linda

AU - Rayan, Anwar

AU - DeCarli, Adriano

AU - Tortora, Giampolo

AU - Sileikis, Audrius

AU - Barauskas, Giedrius

AU - Eriksson Steigen, Sonja

AU - Ikdahl, Tone

AU - Malecka-Panas, Ewa

AU - Silva, Filipe Santos

AU - Barbu, Traian Sorin

AU - Popescu, Irinel

AU - Durisova, Maria

AU - Majekova, Magdalena

AU - Dolzan, Vita

AU - Genc, Lutfi

AU - Yildirim, Hatice

AU - Crnogorac-Jurcevic, Tajana

AU - Brand, Angela

AU - Milne, Roger

AU - Costello, Eithne

AU - Bulchholz, Malte

AU - Greenhalf, Bill

AU - behalf of the COST Action BM1204 participants

PY - 2013/4/20

Y1 - 2013/4/20

N2 - Background: Large-scale international collaboration is essential to decipher relevant information in the context of omics-scale interrogations in cancer research. This is even more important for rare and fatal diseases like pancreas cancer (PC). Methods: The COST Action BM1204 is a unique platform to facilitate the collaboration of a broad range of European and international PC multidisciplinary research groups in order to: (1) integrate knowledge and experience in a multidisciplinary way 'from cell to society', (2) promote the application of uniform study tools and protocols, (3) foster their optimal use by early-stage researchers, (4) enhance the mobility and training of researchers, and (5) disseminate the results produced to the broader society. Results: This Action will develop novel interdisciplinary tools for collaborative research to improve our understanding of PC and its prevention, diagnosis and treatment. It also aims to answer questions related to the etiology, early detection, evidence-based and personalized treatment, and health management for PC. Furthermore, the Action will contribute to new insights into PC personalized medicine and beyond as well as to the understanding of complex and rare diseases taking PC as a best practice example. The Action aims at attracting young scholars across a range of disciplines in collaboration with more experienced researchers and enhancing active European participation in the international scenario of PC research. Conclusion: The ultimate aim is to foster PC research in Europe and to coordinate this effort with other international initiatives to reduce disease mortality.

AB - Background: Large-scale international collaboration is essential to decipher relevant information in the context of omics-scale interrogations in cancer research. This is even more important for rare and fatal diseases like pancreas cancer (PC). Methods: The COST Action BM1204 is a unique platform to facilitate the collaboration of a broad range of European and international PC multidisciplinary research groups in order to: (1) integrate knowledge and experience in a multidisciplinary way 'from cell to society', (2) promote the application of uniform study tools and protocols, (3) foster their optimal use by early-stage researchers, (4) enhance the mobility and training of researchers, and (5) disseminate the results produced to the broader society. Results: This Action will develop novel interdisciplinary tools for collaborative research to improve our understanding of PC and its prevention, diagnosis and treatment. It also aims to answer questions related to the etiology, early detection, evidence-based and personalized treatment, and health management for PC. Furthermore, the Action will contribute to new insights into PC personalized medicine and beyond as well as to the understanding of complex and rare diseases taking PC as a best practice example. The Action aims at attracting young scholars across a range of disciplines in collaboration with more experienced researchers and enhancing active European participation in the international scenario of PC research. Conclusion: The ultimate aim is to foster PC research in Europe and to coordinate this effort with other international initiatives to reduce disease mortality.

UR - http://www.scopus.com/inward/record.url?scp=84899918007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899918007&partnerID=8YFLogxK

U2 - 10.1159/000355937

DO - 10.1159/000355937

M3 - Article

VL - 16

SP - 305

EP - 312

JO - Public Health Genomics

JF - Public Health Genomics

SN - 1662-4246

IS - 6

ER -